Birth Control- I dropped and lost one of the pills?

I lost one of the first week pills. I've been on the pill for over a year. Is it safe to have sex?

Have you read the pamphlet that came with your pill pack?

You should have another form of contraceptive just in case (condom) for a week. Read in you pamphlet what to do if you miss one of the first week pills.

yes but still use a condom just in case
You should be ok. Take the next day pill around 8 hours earlier then you usually do and then go back to your regular schedule Your going to be perfectly fine.
It depends on which pill it was. The packaging information explains what to do. If you don't have the packaging then google the name of the pills.
Just take the next one in the pack. if you skip a day you can get pregnant if it is time for your body to ovulate.
"FDA wonders if The Pill still works well: Federal advisors may vote on more stringent guidelines for birth control drugs; concerned about effectiveness."

By Aaron Smith, CNNMoney.com, staff writer
January 23 2007: 2:29 PM EST

NEW YORK (CNNMoney.com) -- FDA advisors will consider on Tuesday and Wednesday if birth control drugs need more stringent guidelines for safety and effectiveness.

The FDA is concerned over the increase in pregnancies over the last 10 years among women participating in clinical trials for birth control drugs. The agency said this could be the result of inferior products, improper use, or other factors.

The outcome of these meetings could affect the 13 million-plus women and girls who take birth control pills in America, and the estimated $4 billion market for birth control drugs, dominated by Barr Pharmaceuticals (up $0.18 to $55.70, Charts), Watson Pharmaceuticals (up $0.05 to $26.60, Charts), Johnson & Johnson (down $0.88 to $66.30, Charts) and Wyeth (down $0.80 to $50.10, Charts).

Unlike other advisory meetings it is unclear whether the panel will vote or take any other action.

The advisors will focus on the continued study of drugs after they are approved and enter the market, the effectiveness of drugs, and whether their benefits outweigh their safety risks, according to FDA documents. Much of the discussion will probably center on the success and failure rate of birth control drugs. If the advisors vote, it would be considered by the agency, which follows the advice of its experts most of the time.

Panelists will consider the inclusion of smokers, overweight women, and women with a family history of strokes in clinical trials, as well as the role of non-U.S. studies in the American population, according to documents. Also, panelists will consider whether changes should be imposed on the kind of risk and benefit information that is included on a drug's label.
http://money.cnn.com/2007/01/23/news/com...